» Articles » PMID: 9794479

Androgens Induce the Expression of Vascular Endothelial Growth Factor in Human Fetal Prostatic Fibroblasts

Overview
Journal Endocrinology
Specialty Endocrinology
Date 1998 Oct 30
PMID 9794479
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Androgens are known to directly stimulate prostate cancer cell growth. We have previously reported that LNCaP prostate cancer cells were dependent upon stromal coinoculation for growth in nude mice and that the stromal cells secreted a potent angiogenic factor, vascular endothelial growth factor (VEGF), which stimulated tumor angiogenesis. Immunohistochemical staining localized VEGF expression primarily to the stromal cells of human fetal and adult hyperplastic prostates, with both stromal and epithelial cell VEGF expression in prostate cancer. In the present studies, we test the hypothesis that androgens, in addition to their direct effects on prostate epithelial cells, have indirect effects on these cells via up-regulation of stromal VEGF production and angiogenesis. Primary cultures of human prostate fetal fibroblasts were treated with dihydrotestosterone (DHT), and the effects on VEGF messenger RNA (mRNA) expression were determined by Northern blotting. DHT (10 nM) increased VEGF mRNA levels maximally after 2 h. Nuclear run-on transcription assays demonstrated a 2-fold increase in the VEGF transcription rate 2 h after the addition of DHT. VEGF mRNA stability was unaffected by DHT addition. VEGF protein levels were determined by enzyme-linked immunosorbent assay and were increased 2-fold 4 h after DHT addition. These data indicate that androgens increase VEGF transcription and secretion of biologically active VEGF from human prostatic stroma. Androgens, therefore, may indirectly enhance prostate growth via up-regulation of VEGF from the surrounding stroma.

Citing Articles

Evaluation of the Antioxidant and Antiangiogenic Activity of a Pomegranate Extract in BPH-1 Prostate Epithelial Cells.

Consoli V, Buro I, Gulisano M, Castellano A, DAmico A, DAgata V Int J Mol Sci. 2023; 24(13).

PMID: 37445909 PMC: 10342071. DOI: 10.3390/ijms241310719.


Activation of GPR56, a novel adhesion GPCR, is necessary for nuclear androgen receptor signaling in prostate cells.

Singh J, Dagar M, Dagar G, Kumar S, Rawal S, Sharma R PLoS One. 2020; 15(9):e0226056.

PMID: 32881870 PMC: 7470385. DOI: 10.1371/journal.pone.0226056.


6-sialyllactose ameliorates dihydrotestosterone-induced benign prostatic hyperplasia through suppressing VEGF-mediated angiogenesis.

Kim E, Jin B, Chung T, Bae S, Park H, Ryu D BMB Rep. 2019; 52(9):560-565.

PMID: 31383249 PMC: 6774418.


, , and : Novel Potential Biomarkers and Therapeutic Targets in Castration-Resistant Prostate Cancer.

Salah Fararjeh A, Liu Y Int J Mol Sci. 2019; 20(11).

PMID: 31181727 PMC: 6600524. DOI: 10.3390/ijms20112802.


A herbal formula, comprising and bee-pollen, inhibits development of testosterone-induced benign prostatic hyperplasia in male Wistar rats.

Park H, Kim S, Lee S, Chung J, Lee B, Na S Saudi J Biol Sci. 2018; 24(7):1555-1561.

PMID: 30294225 PMC: 6169514. DOI: 10.1016/j.sjbs.2015.10.020.